CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase 3 XRay Vision study design - supplementary material
Authors
Andre Konig (17766383)
Christophe Le Tourneau (10646294)
+8Â more
Hisham Mehanna (298212)
Jonathan D. Schoenfeld (12100222)
Makoto Tahara (5686613)
Marcis Bajars (7546727)
Pauline Witzler (17766386)
Robert Haddad (3501962)
Robert L. Ferris (616113)
Sue S. Yom (9563173)
Publication date
10 January 2024
Publisher
Doi
Cite
Abstract
Infographic</p
Similar works
Full text
Available Versions
FigShare
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:figshare.com:article/24972...
Last time updated on 24/01/2024
